Benjamin Edwards’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$269K Buy
497
+24
+5% +$12.4K ﹤0.01% 1295
2026
Q2
$256K Buy
+473
New +$266K ﹤0.01% 1300

Other funds holding UTHR

Benjamin Edwards's UTHR Position: Q3 2026 in Review

Benjamin Edwards increased its United Therapeutics (UTHR) stake by 5.1% in Q3 2026, buying an estimated $12.4K and bringing the position to 497 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #1295.

Benjamin Edwards first reported a position in UTHR in Q2 2026 and has held it in 2 quarters since. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Benjamin Edwards held 497 shares of United Therapeutics worth $269K as of Q3 2026.
  • Benjamin Edwards bought 24 United Therapeutics shares in Q3 2026, an estimated $12.4K.
  • United Therapeutics made up ﹤0.01% of Benjamin Edwards's portfolio in Q3 2026, its #1295 holding.
  • Benjamin Edwards first reported a position in United Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.